Patients who have been treated for heart failure and experience an improvement in their pump function are still at higher ...

Patients who have been treated for heart failure and experience an improvement of their pump function, are still at higher risk of heart-related death or hospitalization if they stop taking heart ...

Patients who have been treated for heart failure and experience an improvement of their pump function, are still at higher ...

or MRA (mineralocorticoid receptor antagonists) had between 36 and 38 percent higher risk of heart-related death or hospitalisation within one year of medication discontinuation. However ...

or MRA (mineralocorticoid receptor antagonists) had between 36 and 38 percent higher risk of heart-related death or hospitalisation within one year of medication discontinuation. However ...

Mar. 17, 2025 — New hope offered by a pharmacy team for treating heart disease by sharing insights into the fundamental process of how the heart is formed in ... Minimal TV Viewing May Be ...

研究显示，停药1 年内，心血管死亡/心衰住院风险显著增加，停用RAS抑制剂/ARNI可导致心血管死亡/心衰住院风险增加38%，停用MRA可导致风险增加36%，但停用β受体阻滞剂 影响不大。 与LVEF ...

Correspondence to Shuzheng Lv, Department of Cardiology, Beijing An Zhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, Anzhenli Avenue, Chao Yang ...